Jefferies reiterates Regeneron stock rating ahead of patent hearing

🇺🇸 Investing.com (US) —
Jefferies reiterates Regeneron stock rating ahead of patent hearing

AI Summary

Jefferies reiterated its rating on Regeneron stock ahead of a patent hearing. The headline does not specify the rating or the patent dispute's details.

Markets Health Jefferies Regeneron stock rating patent hearing biopharmaceuticals

Read original source →